O. Levy

发表

Synthesis & biological evaluation of PYY(3-36) analogs substituted with alanine.

Soumitra S Ghosh, C. Jodka, A. Lwin, 2009, Advances in experimental medicine and biology.

Guanylpiperidine peptidomimetics: potent and selective bis-cation inhibitors of factor Xa.

R. Nutt, S. Tamura, J. Ho, 2000, Bioorganic & medicinal chemistry letters.

New Synthetic Technology for Efficient Construction of α-Hydroxy-β-amino Amides via the Passerini Reaction1

Andrew Nguyen, J. E. Semple, O. Levy, 2000 .

Novel, potent and selective chimeric FXa inhibitors featuring hydrophobic P1-ketoamide moieties.

D. Siev, J. E. Semple, N. K. Minami, 2000, Bioorganic & medicinal chemistry letters.

A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents

B. Gedulin, C. Jodka, D. Parkes, 2013, Diabetes, obesity & metabolism.

Potent and selective thrombin inhibitors incorporating the constrained arginine mimic l-3-piperidyl(N-guanidino)alanine at P1.

R. Nutt, A. Tulinsky, E. Dempsey, 1996, Journal of medicinal chemistry.

Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action

Soumitra S Ghosh, C. Jodka, D. Parkes, 2014, PloS one.

Discovery of SCH446211 (SCH6): a new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication.

S. Tamura, S. Kemp, M. Lim-Wilby, 2006, Journal of medicinal chemistry.

Strategies in the Design of Inhibitors of Serine Proteases of the Coagulation Cascade - Factor Xa

I. Lasters, S. Tamura, P. Stanssens, 1995, European Journal of Medicinal Chemistry.

New Synthetic Technology for Efficient Construction of α‐Hydroxy‐β‐amino Amides via the Passerini Reaction.

J. E. Semple, O. Levy, T. D. Owens, 2001 .

Improved Glucose Control and Reduced Body Weight in Rodents with Dual Mechanism of Action Peptide Hybrids

Soumitra S Ghosh, B. Gedulin, C. Jodka, 2013, PloS one.

Hepatitis C virus NS3-4A serine protease inhibitors: SAR of P'2 moiety with improved potency.

S. Tamura, N. Yao, B. Malcolm, 2005, Bioorganic & medicinal chemistry letters.

Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.

A. Tulinsky, K. Håkansson, R. Arni, 1998, Biochemistry.

Optimization of a continuous assay for obtaining sensitive kinetic data on the inhibition of the HCV NS3 protease

O. Levy, S. Anderson, P. Bergum, 2002 .